Auszug
Die Multiple Sklerose (MS) ist eine chronische, entzündlich-demyelinisierende Erkrankung des Zentralnervensystems (ZNS), betrifft also Gehirn und Rückenmark, wobei heute eine autoimmune Ätiologie allgemein angenommen wird. Sie ist die häufigste Entmarkungserkrankung des ZNS in Nordeuropa und Nordamerika (Prävalenz 1:1000) und die häufigste chronisch-neurologische Erkrankung, die bei jungen Erwachsenen zu bleibender Behinderung führt.
Chapter PDF
Similar content being viewed by others
Literatur
Arredondo LR, Deng C, Ratts RB, Lovett-Racke AE, Holtzmann DM, Racke MK (2001) Role of nerve growth factor in experimental autoimmune encephalomyelitis. Eur J Immunol31:625–633
Beatty WW, Aupperle RL (2002) Sex differences in cognitive impairment in multiple sclerosis. Clin Neuropsychol 16:472–480
Beck R (1913) Multiple Sklerose, Schwangerschaft und Geburt. Dtsch. Zeitschr. f. Nervenheilkunde 46:127–145
Birk K, Ford C, Smeltzer S, Ryan D, Millar R, Rudick RA (1990) The clinical course of multiple sclerosis during pregnancy and the puerperium. Arch Neurol 47:738–742
Brown RF, Tennant CC, Sharrock M, Hodgkinson S, Dunn SM, Pollard JD (2006) Relationship between stress and relapse in multiple sclerosis: part I. Important features. Multiple Sclerosis 12:453–464
Brück W, Stadelmann C (2005) The spectrum of multiple sclerosis: new lessons from pathology. Curr Opin Neurol 18:221–224
Cepok S, Zhou D, Srivastava R, Nessler S, Stei S, Büssow K, Sommer N, Hemmer B (2005) Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis. J Clin Invest 115:1352–1360
Confavreux C, Hutchinson M, Hours MM, Cotinvis-Tourniaire P, Moreau T (1998) Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Eng J Med 339:285–291
Craig J, Young CA, Ennis M, Baker G, Boggild M (2003) A randomised controlled trial comparing rehabilitation against standard therapy in multiple sclerosis patients receiving intravenous steroid treatment. J Neurol Neurosurg Psychiatry 74:1225–1230
DasGupta R, Wiseman OJ, Kanabar G, Fowler CJ (2004) Efficacy of sildenafil in the treatment of female sexual dysfunction due to multiple sclerosis. J Urol 171:1189–1193
Elian M, Nightingale S, Dean G (1990) Multiple sclerosis among United Kingdom-born children of immigrants from the Indian subcontinent, Africa and the West Indies. J Neurol Neurosurg Psychiatry 53:906–911
Flachenecker P, Bihler I, Weber F, Gottschalk M, Toyka KV, Rieckmann P (2004) Cytokine mRNA expression in patients with multiple sclerosis and fatigue. Mult Scler 10:165–169
Foley FW, LaRocca NG, Sanders AS, Zemon V (2001) Rehabilitation of intimacy and sexual dysfunction in couples with multiple sclerosis. Multiple Sclerosis 7:417–421
Grasser A, Möller A, Backmund H, Yassouridis A, Holsboer F (1996) Heterogeneity of hypothalamic-pituitary-adrenal system response to a combined dexamethasone-CRH test in multiple sclerosis. Exp Clin Endocrinol 104:31–37
Harrison T, Stuifbergen A, Adachi E, Becker H (2004) Marriage, impariment, and acceptance in persons with multiple sclerosis. West J Nurs Res 26:266–285
Haupts M (2005) Depression. In: Henze, T (Hrsg) Symptomatische Therapie der Multiplen Sklerose. Thieme, Stuttgart New York, S 105–112
Healy B (1991) The Yentl syndrome. N Engl J Med 325:274–276
Heuser I, Yassouridis A, Holsboer F (1994) The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. J Psychiat Res 28:314–356
Kantarci OH, Barcellos LF, Atkinson EJ, Ramsay PR, Lincoln R, Achenbach SJ, De Andrade M, Hauser SL, Weinshenker BG (2006) Men transmit MS more often to their children vs women. The Carter effect. Neurology 67:305–310
Kerschensteiner M, Stadelmann C, Dechant G, Wekerle H, Hohlfeld R (2003) Neurotrophic cross-talk between the nervous and immune systems: Implications for neurological diseases. Ann Neurol 53:292
Kulig K (1956) Gestationsprozesse und Multiple Sklerose. Dtsch Zeitschrf Nervenheilkunde 174:460–468
Lassmann H (2003) Axonal injury in multiple sclerosis. J Neurol Neurosurg Psych 74:695–697
Levin N, Mor M, Ben-Hur T (2003) Patterns of misdiagnosis of multiple sclerosis. Isr Med Assoc J 5:489–490
Liu C, Playford ED, Thompson AJ (2003) Does neurorehabilitation have a role in relapsing-remitting multiple sclerosis? J Neurol 250:1214–1218
McCarthy M (2000) The »gender gap« in autoimmune disease. Lancet 356:1088
Moalem G, Leibowitz-Amit R, Yoles E, Mor F, Cohen IR, Schwartz M (1999) Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nature Med 5:49–55
Mohr DC, Hart SL, Julian L, Cox D, Pelletier D (2004) Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis. BMJ 328:731
Mosmann TR, Coffman RL (1989) TH1 and TH2 cells: different patterns of lymphokine secretion lead to different function properties. Annu Rev Immunol 7:145–173
Nisipeanu P, Korczyn AD (1993) Psychological stress as risk factor for exacerbations in multiple sclerosis. Neurology 43:1311–1312
Polman CH, Reingold SC, Edan G, et al. (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the »McDonald Criteria«. Ann Neurol 58:840–846
Poser S, Wikstrom J, Bauer HJ (1979) Clinical data and the identification of spezial forms of multiple sclerosis in 1271 cases studied with standardized documentation system. J Neurol Sci 40:159–168
Raghupathy R (1997) Th1-type immunity is incompatible with successful pregnancy. Immunol today 18:478–482
Runmaker B, Andersen O (1995) Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis. Brain 118:253–261
Savettieri G, Messina D, Andreoli V, Bonavita S, Caltagirone C, Cittadella R, et al. (2004) Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis. J Neurol 251:1208–1214
Schäfer U, Poser S (2002) Multiple Sklerose. Ein Leitfaden für Betroffene, 7. Aufl. Blackwell, Berlin, S 87f
Schumann EM, Kümpfel T, Then Bergh F, Trenkwalder C, Holsboer F, Auer DP (2002) Activity of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: correlations with Gadolinium-enhancing lesions and ventricular volume. Ann Neurol 51:763–767
Sicotte NL, Liva SM, Klutch R et al. (2002) Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann Neurol 52:421–428
Siegert RJ, Abernethy DA (2005) Depression in multiple sclerosis-4 review. J Neurol Neurosurg Psychiatry 76:469–475
Sommer N, Zipp F, Rösener M, Dichgans J, Martin R (1996) Der Einfluß genetischer Faktoren auf die multiple Sklerose. Nervenarzt 67:457–464
Stenager EN, Stenager E, Koch-Henriksen N, et al. (1992) Suicide and multiple sclerosis: an epidemiological investigation. J Neurol Neurosurg Psychiatry 55:542–545
Zarei M (2006) Clinical characteristics of cortical multiple sclerosis. J Neurol Sci 245;53–58
Zorzon M, Zivadinov R, Monti Bragadin L, Moretti R, De Masi R, Nasuelli D, Cazzato G (2001) Sexual dysfunction in multiple sclerosis: a 2-year follow-up study. J Neurol Sci 187:1–5
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Sommer, N. (2007). Multiple Sklerose — eine neuroimmunendokrine Erkrankung. In: Lautenbacher, S., Güntürkün, O., Hausmann, M. (eds) Gehirn und Geschlecht. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-71628-0_15
Download citation
DOI: https://doi.org/10.1007/978-3-540-71628-0_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-71627-3
Online ISBN: 978-3-540-71628-0
eBook Packages: Humanities, Social Science (German Language)